Anna‐Greta Nylander
Anna‐Greta Nylander publishes mostly in Psychiatry and Mental health, Surgery and Economics and Econometrics, on topics such as Schizophrenia research and treatment, Health Systems, Economic Evaluations, Quality of Life and Neuropeptides and Animal Physiology.
- World rank
- #2,387,274 of 7,710,434 ranked researchers
- Rank in Denmark
- #17,968 of 43,819
- Works
- 49
- Citations
- 1.1k
- Citations per work
- 23.5
What does Anna‐Greta Nylander research?
Anna‐Greta Nylander's work is mostly in Medicine (31%), Economics, Econometrics and Finance (8%), Biochemistry, Genetics and Molecular Biology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else2143.5%
- Health Sciences1531.1%
- Medicine1531.1%
- Social Sciences713.8%
- Life Sciences611.6%
- 1Psychiatry and Mental health22% of their works
- 2Surgery9% of their works
- 3Economics and Econometrics8% of their works
- 4Cellular and Molecular Neuroscience6% of their works
- 5Molecular Biology6% of their works
- 6Clinical Psychology6% of their works
Research topics
- Schizophrenia research and treatment
- Health Systems, Economic Evaluations, Quality of Life
- Neuropeptides and Animal Physiology
- Neuroendocrine Tumor Research Advances
- Helicobacter pylori-related gastroenterology studies
- Treatment of Major Depression
- Pancreatic function and diabetes
- Healthcare Decision-Making and Restraints
Which keywords describe Anna‐Greta Nylander's research?
The keywords of their largest research topics: Antipsychotic Drugs, Neurocognitive Deficits, Depression, Cost-effectiveness Analysis, Quality of Life, Neuropeptides, Receptors and Neuroendocrine Tumors.
- Psychiatric Treatment
- Ketamine
- Antidepressant
- Gastric Cancer
- Neuroendocrine Tumors
- Neuropeptides
- Cost-effectiveness Analysis
- Neurocognitive Deficits
- Antipsychotic Drugs
- Depression
- Quality of Life
- Receptors
- Pancreatic Neuroendocrine Tumors
- Helicobacter pylori
- Informed Consent
- Pancreatic Islets
- ß-Cell Dysfunction
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Antipsychotic Drugs231 topic
- Neurocognitive Deficits231 topic
- Depression122 topics
- Cost-effectiveness Analysis111 topic
- Quality of Life111 topic
- Neuropeptides81 topic
- Receptors81 topic
- Neuroendocrine Tumors71 topic
- Pancreatic Neuroendocrine Tumors71 topic
- Gastric Cancer51 topic
- Helicobacter pylori51 topic
- Antidepressant41 topic
- Informed Consent41 topic
- Ketamine41 topic
- Pancreatic Islets41 topic
- Psychiatric Treatment41 topic
- ß-Cell Dysfunction41 topic
Where does Anna‐Greta Nylander work?
Anna‐Greta Nylander's main affiliation in the publication record is Lundbeck (Denmark), Denmark.
How many publications and citations does Anna‐Greta Nylander have?
OpenAlex counts 49 works and 1,150 citations for Anna‐Greta Nylander, an h-index of 18, ranking #2,387,274 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Anna‐Greta Nylander. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.